Open Access Research Article

Biosimilar FSH Preparations Versus Highly Purified Urinary FSH for Simple Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome

Abd El Naser Abd El Gaber Ali1, Mustafa M Khodry1, Ahmed AM Mohammad1, Mahmoud I El Rasheedy2 and Ahmed M Abbas3*

1Department of Obstetrics and Gynecology, South Valley University, Egypt

2Department of Obstetrics and Gynecology, Al Azhar University, Egypt

3Department of Obstetrics and Gynecology, Assiut University, Egypt

Corresponding Author

Received Date: November 01, 2018;  Published Date: November 13, 2018

Abstract

Objective: To compare the efficacy of biosimilar FSH preparations and highly purified urinary FSH in ovulation induction in PCOs infertile women.

Patients and Methods: 100 infertile women with PCOs had been included in the study. Patients were randomly classified according to ovulation induction drugs used into 2 groups (Group I: included 50 infertile women received biosimilar FSH preparations and Group II: included 50 infertile women received highly purified urinary FSH. All cases were monitored for follicular development by transvaginal ultrasound.

Results: There was a mildly statistically significant difference between biosimilar FSH preparations group and highly purified urinary FSH in the mean ±SD of gonadotrophins doses used, the duration of stimulation, the number of mature follicles (p< 0.05), but there was a highly statistically significant in endometrial thickness at time of HCG triggering (p< 0.01). There was a mildly statistically significant difference in pregnancy rates (p< 0.05). There was a mildly statistically significant difference in development of hyperstimulation syndrome and twins’ pregnancies (p< 0.05).

Conclusion: Biosimilar FSH preparations were better than the highly purified urinary FSH in ovulation induction in PCOs infertile women (short duration and low doses of stimulation, significant increase in growing follicles number, enhancement in endometrial thickness and increased pregnancy rate). So, this study recommends the use of biosimilar preparations of FSH in ovulation induction in PCOs infertile women.

Keywords: Biosimilar FSH; Highly purified urinary FSH (HP-FSH); Polycystic ovary syndrome (PCOs)

Citation
Signup for Newsletter
Scroll to Top